Cagrilintide

A long-acting amylin analog peptide that appears in metabolic and satiety-signaling research literature.

Cagrilintide is a synthetic peptide characterized in the literature as a long-acting analog of amylin. As a research material it is handled as a defined amylin-family peptide and is the subject of research examining amylin and calcitonin receptor signaling. This page is background about the molecule and is not medical guidance or intended for human use.

Classification and structure

Cagrilintide is classified as a peptide, structurally an amylin analog with modifications intended to extend its stability and circulating half-life in study systems. It is modeled on the amylin hormone framework and interacts with amylin-family receptors in research settings. It is supplied strictly as a research material.

Areas of research

In the published literature, cagrilintide appears most often in the following research areas.

• Amylin receptor signaling — Investigated in models examining amylin and calcitonin receptor engagement.
• Satiety-signaling research — Appears in the literature on peripheral satiety and energy-balance signaling models.
• Metabolic pathway models — Studied in research examining metabolic and glucoregulatory pathways.

As always in this library, describing a compound as “studied in” an area is a statement about where scientific attention has gone — not a claim that it produces any result in humans or animals.

Handling and verification

Lyophilized cagrilintide is generally kept cold and dry until reconstitution in the laboratory setting. Every in-stock lot ships with a third-party certificate of analysis that can be verified by its lot number.